Skip to content
Study details
Enrolling now

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

Wright State University
NCT IDNCT07116408ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

20

Study length

about 3 years

Ages

18+

Locations

1 site in OH

What this study is about

Researchers are testing whether a treatment that numbs the sphenopalatine ganglion, sprayed into the back of the nose, can reduce headache pain in people who have had bleeding from a brain aneurysm. This treatment aims to provide better pain relief without causing many side effects compared to standard medications. The trial will track how much pain medication patients need and their reported pain levels before and after receiving this new treatment.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Lidocaine (drug)
  • 2.Use Tx 360

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
topical

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

lidocaine

Drug routes

topical (Topical Cream)